Regarding the effect on cancer metastasis, the co-prescription of metformin with DPP-4 inhibitors could prevent an elevated risk of thyroid cancer metastasis with DPP-4 inhibitor alone in T2DM patients [130]. Here, DPP4 is linked to cancer.